Skip to content
2000
image of The Comparison Between Dietary Vitamin A Deficiency and the CRP Level in Alzheimer’s Disease in Patients with Type 2 Diabetes: A Case-Control Study

Abstract

Background

Type 2 Diabetes Mellitus (T2DM) patients are 50-60% more likely to develop Alzheimer’s Disease (AD). T2DM has many risk factors, including inflammation. Previous studies suggest that CRP was higher in diabetic patients, indicating that it may play a role in diabetogenesis and insulin resistance. Many diseases are prevalent in older age, including T2DM and AD. Moreover, multiple studies suggested a possible association between vitamin A levels, AD, and T2DM. However, the role of Vitamin A in Alzheimer's patients with T2DM has not yet been fully investigated. Therefore, this study aims to measure the association between dietary vitamin A deficiency and AD patients with T2DM in King Abdulaziz Medical City, Jeddah, Western Region, Saudi Arabia, to help expand the preexisting knowledge of the diagnostic risk factors of both the diseases and to determine the significance of vitamin A as a nutritional factor in their management and prevention.

Methods

This case-control study investigates the prevalence of vitamin A deficiency (VAD) among Alzheimer's disease (AD) patients with and without type 2 diabetes mellitus (T2DM). Participants included 103 AD patients aged 40 and older from the National Guard Hospital in Saudi Arabia, recruited between 2016 and 2022. Data collection occurred in two phases: first, through a review of medical records to gather demographic and health history information, including retrospective blood tests for systemic C-reactive protein (CRP) levels and comorbidities; second, using the HKI Food Frequency Questionnaire (FFQ) to assess dietary intake of vitamin A-rich foods over the past week, with caregiver interviews facilitating this process. Each subject was also prospectively interviewed to assess the presence of VAD events. The study aims to elucidate the relationship between dietary habits and VAD prevalence in AD patients, contributing to the understanding of nutritional impacts on cognitive health in this population.

Results

This study examined demographic and clinical characteristics of the Alzheimer’s group, with 70.1% having both Alzheimer's with T2DM and 29.9% having Alzheimer's alone. Significant differences in age were found (-value = 0.03), but gender distribution was similar (-value = 0.45). Most caregivers were sons, and 81.43% of patients received oral feeding. Comorbidities included hypertension (94.90%) and dyslipidemia (63.4%), with significant differences (-value < 0.001). Correlation analyses showed weak negative correlations between CRP and vitamin A concentrations in both groups (Alzheimer with T2DM: -value = 0.713, rho = -0.064; AD only: -value = 0.223, rho = -0.121). Age and vitamin A levels also exhibited weak correlations: Alzheimer’s with 2DM (-value = 0.727, rho = 0.053) and Alzheimer’s only (-value = 0.223, rho = -0.253), neither of them was statistically significant. Symptoms of vitamin A deficiency were noted in Alzheimer's patients with T2DM, with no significant differences between groups. Dietary intake was lower for vitamin B complex, vitamin D, and multivitamins in AD patients with T2DM.

Conclusion

The findings highlight the need for further investigation into the factors influencing vitamin A metabolism in these populations. Additionally, the prevalence of vitamin A deficiency symptoms and low dietary intake of essential nutrients among patients with Alzheimer's with T2DM suggests critical areas for nutritional intervention. Addressing these deficits may improve patient outcomes and enhance overall care strategies for individuals living with Alzheimer's disease.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/car/10.2174/0115672050396361250730115305
2025-10-17
2025-11-02

  • From This Site

    /content/journals/car/10.2174/0115672050396361250730115305
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Breijyeh Z. Karaman R. Comprehensive review on Alzheimer’s disease: Causes and treatment. Molecules 2020 25 24 5789 10.3390/molecules25245789 33302541
    [Google Scholar]
  2. Day WAs 2021 Available from:https://wwwmohgovsa/en/%20HealthAwareness/healthDay/2020/Pages/HealthDay-2020-09-%2021aspx%202021
  3. Nguyen T.T. Ta Q.T.H. Nguyen T.K.O. Nguyen T.T.D. Van Giau V. Type 3 diabetes and its role implications in Alzheimer’s disease. Int. J. Mol. Sci. 2020 21 9 3165 10.3390/ijms21093165 32365816
    [Google Scholar]
  4. Barbagallo M. Dominguez L.J. Type 2 diabetes mellitus and Alzheimer’s disease. World J. Diabetes 2014 5 6 889 893 10.4239/wjd.v5.i6.889 25512792
    [Google Scholar]
  5. Faqih N.T. Ashoor A.F. Alshaikh S.A. Maglan A.F. Jastaniah N. Alshaikh S. Association of Alzheimer’s disease and insulin resistance in King Abdulaziz medical city, Jeddah. Cureus 2021 13 11 e19811 10.7759/cureus.19811 34956794
    [Google Scholar]
  6. Valdés-Ramos R. Ana Laura G-L. Beatriz Elina M-C. Alejandra Donaji B-A. Vitamins and type 2 diabetes mellitus. Endocr. Metab. Immune Disord. Drug Targets 2015 15 1 54 63 10.2174/1871530314666141111103217 25388747
    [Google Scholar]
  7. Gheevarghese RM False negative results for blood tested in the presence of chemical interferents. 2021
    [Google Scholar]
  8. Nelson D.L. Cox M.M. Lehninger Principles of Biochemistry. W. H. Freeman 2021
    [Google Scholar]
  9. Hodge C. Taylor C. Vitamin A Deficiency. Treasure Island (FL): StatPearls Publishing 2025
    [Google Scholar]
  10. Zhao T. Liu S. Zhang R. Global burden of vitamin A deficiency in 204 countries and territories from 1990–2019. Nutrients 2022 14 5 950 10.3390/nu14050950 35267925
    [Google Scholar]
  11. Ray S.K. Das B.C. Dasgupta S. Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease. Neural Regen. Res. 2019 14 11 1880 1892 10.4103/1673‑5374.259604 31290437
    [Google Scholar]
  12. Ono K. Yamada M. Vitamin A and Alzheimer’s disease. Geriatr. Gerontol. Int. 2012 12 2 180 188 10.1111/j.1447‑0594.2011.00786.x 22221326
    [Google Scholar]
  13. Ralston S.H. Penman I.D. Strachan M.W.J. Hobson R. Davidson’s principles and practice of medicine. Elsevier 2018
    [Google Scholar]
  14. Lu G. Liu W. Huang X. Zhao Y. Complement factor H levels are decreased and correlated with serum C-reactive protein in late-onset Alzheimer’s disease. Arq. Neuropsiquiatr. 2020 78 2 76 80 10.1590/0004‑282x20190151 32022122
    [Google Scholar]
  15. Fernandes A. Tábuas-Pereira M. Duro D. C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer’s disease dementia. Exp. Gerontol. 2020 138 111004 10.1016/j.exger.2020.111004 32561398
    [Google Scholar]
  16. Elahi M.M. Kong Y.X. Matata B.M. Oxidative stress as a mediator of cardiovascular disease. Oxid. Med. Cell. Longev. 2009 2 5 259 269 10.4161/oxim.2.5.9441 20716913
    [Google Scholar]
  17. De Dios O. Navarro P. Ortega-Senovilla H. Plasma retinol levels and high-sensitivity C-reactive protein in prepubertal children. Nutrients 2018 10 9 1257 10.3390/nu10091257 30205424
    [Google Scholar]
  18. Persson V. Greiner T. Islam S. Gebre-Medhin M. The Helen Keller International food-Frequency Method. New York, NY Helen Keller International 1998
    [Google Scholar]
  19. Eigbefoh J.O. Okpere E.E. Ande B. Asonye C. How useful is the Helen Keller food frequency chart in the determination of the vitamin A status in pregnancy? J. Obstet. Gynaecol. 2005 25 2 123 127 10.1080/01443610500040653 15814387
    [Google Scholar]
  20. Beam C.R. Kaneshiro C. Jang J.Y. Reynolds C.A. Pedersen N.L. Gatz M. Differences between women and men in incidence rates of dementia and Alzheimer’s disease. J. Alzheimers Dis. 2018 64 4 1077 1083 10.3233/JAD‑180141 30010124
    [Google Scholar]
  21. Chou H.H. Tsou M.T. Hwang L.C. Nasogastric tube feeding versus assisted hand feeding in-home healthcare older adults with severe dementia in Taiwan: A prognosis comparison. BMC Geriatr. 2020 20 1 60 10.1186/s12877‑020‑1464‑9 32059646
    [Google Scholar]
  22. Luan Y. Yao Y. The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases. Front. Immunol. 2018 9 1302 10.3389/fimmu.2018.01302 29951057
    [Google Scholar]
  23. Ahmed A.S. Elgharabawy R.M. AL-Najjar AH. Ameliorating effect of anti-Alzheimer’s drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer’s disease. Exp. Biol. Med. 2017 242 13 1335 1344 10.1177/1535370217711440 28534431
    [Google Scholar]
  24. Dandona P. Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein. In: Mayo Clinic Proceed Elsevier 2008 83 3 333 342 10.4065/83.3.333
    [Google Scholar]
  25. Anderson G. Physiological processes underpinning the ubiquitous benefits and interactions of melatonin, butyrate and green tea in neurodegenerative conditions. Melatonin Res 2024 7 1 20 46 10.32794/mr112500167
    [Google Scholar]
  26. Ashton A. Clark J. Fedo J. Sementilli A. Fragoso Y.D. McCaffery P. Retinoic acid signalling in the pineal gland is conserved across mammalian species and its transcriptional activity is inhibited by melatonin. Cells 2023 12 2 286 10.3390/cells12020286 36672220
    [Google Scholar]
  27. Zhang W. Zhao C. Wang C. Methylglyoxal accumulation contributes to accelerated brain aging in spontaneously hypertensive rats. Free Radic. Biol. Med. 2024 210 108 119 10.1016/j.freeradbiomed.2023.11.012 37984752
    [Google Scholar]
  28. Md Samsuzzaman Hong S-M. Lee J.H. Depression like-behavior and memory loss induced by methylglyoxal is associated with tryptophan depletion and oxidative stress: A new in vivo model of neurodegeneration. Biol. Res. 2024 57 1 87 10.1186/s40659‑024‑00572‑4 39574138
    [Google Scholar]
  29. Subramanian U. Nagarajan D. All-Trans Retinoic Acid supplementation prevents cardiac fibrosis and cytokines induced by Methylglyoxal. Glycoconj. J. 2017 34 2 255 265 10.1007/s10719‑016‑9760‑5 28091942
    [Google Scholar]
  30. Anderson G. A more holistic perspective of Alzheimer’s disease: Roles of gut microbiome, adipocytes, HPA axis, melatonergic pathway and astrocyte mitochondria in the emergence of autoimmunity. Front. Biosci. 2023 28 12 355 10.31083/j.fbl2812355 38179773
    [Google Scholar]
/content/journals/car/10.2174/0115672050396361250730115305
Loading
The Comparison Between Dietary Vitamin A Deficiency and the CRP Level in Alzheimer’s Disease in Patients with Type 2 Diabetes: A Case-Control Study
Bentham Science Publishers ; https://doi.org/10.2174/0115672050396361250730115305
/content/journals/car/10.2174/0115672050396361250730115305
/content/journals/car/10.2174/0115672050396361250730115305
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: type 2 diabetes mellitus ; inflammation ; CRP ; Alzheimer’s Disease ; vitamin A ; HKI Food Frequency Questionnaire (FFQ)

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test